KEGG Pathways | miR-365-3p | miR-30b-5p/30c | Let-7a-5p | miR-23a | miR-148a | miR-24-3p | miR-92a | miR-193a-3p | miR-423-5p | miR-99b | miR-499 | miR-486 | miR-2339 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immune system | |||||||||||||
B cell receptor signaling pathway | X | X | |||||||||||
T-cell receptor signaling | X | X | |||||||||||
Fc gamma R-mediated, phagocytosis/chemokine signaling | X | X | |||||||||||
Signal transduction | |||||||||||||
MAPK signaling pathway | X | X | X | X | X | X | X | ||||||
ErbB signaling pathway | X | X | X | X | |||||||||
Wnt signaling pathway | X | X | X | X | X | X | |||||||
TGF-beta signaling pathway | X | X | X | X | |||||||||
Calcium signaling pathway | X | X | X | ||||||||||
Phosphatidylinositol pathway | X | X | |||||||||||
ECM-receptor interaction | X | X | |||||||||||
Cellular processes (transport and catabolism, cell motility, cell communication) | |||||||||||||
Endocytosis | X | X | X | ||||||||||
Lysosome/apoptosis | X | X | |||||||||||
Regulation of actin cytoskeleton | X | X | X | X | X | X | X | ||||||
Cell cycle | X | X | X | X | |||||||||
P53 signaling pathway | X | X | X | X | |||||||||
Adherens/tight junction | X | X | |||||||||||
Focal adhesion | X | X | X | X | X | ||||||||
Endocrine system | |||||||||||||
Insulin signaling pathway | X | X | |||||||||||
Adipocytokine signaling pathway | X | X | |||||||||||
GnRH signaling pathway | X | X | X | ||||||||||
Melanogenesis | X | X | X | ||||||||||
Nervous system | |||||||||||||
Long term potentiation | X | X | X | X | |||||||||
Neurotrophin signaling pathway | X | X | X | X | X | X | |||||||
Development: Axon guidance | X | X | X | X | X | X | X | X | X | ||||
Metabolism: Glycerophospholipid metabolism/glycosphingolipid biosynthesis | X | X | |||||||||||
Human diseases | |||||||||||||
Pathways in cancer | X | X | X | X | X | X | X | X | X | ||||
Colorectal cancer | X | X | X | X | X | X | X | X | |||||
Pancreatic cancer | X | X | X | X | |||||||||
Bladder cancer | X | ||||||||||||
Prostate cancer | X | X | X | X | X | X | |||||||
Small cell lung cancer | X | X | X | ||||||||||
Non-small cell lung cancer | X | X | X | X | |||||||||
Thyroid cancer | X | ||||||||||||
Renal cell carcinoma | X | X | X | X | |||||||||
Endometrical cancer | X | X | |||||||||||
Glioma | X | X | X | X | X | ||||||||
Melanoma | X | X | X | X | |||||||||
Type II diabetes mellitus | X | X | |||||||||||
Chronic myeloid leukemia | X | X | X | X | |||||||||
Acute myeloid leukemia | X | X |